Abstract
With the aim to provide more insight into their biology, a series of 79 liposarcomas (LS) representative of all main subtypes was analysed for chromosomal imbalances using comparative genomic hybridization. Based on the genetic data, unsupervised hierarchical clustering unveiled two main LS clusters, each with two subclusters, one comprising three subsets. The first main cluster consisted of one larger subcluster, being characterised by gains/high-level amplifications of chromosomal subregions 12q13–q15, and exclusively included well-differentiated and dedifferentiated LS. A smaller subcluster was set apart on the basis of recurrent gains of 20q13 and 8q24, and mainly comprised pleomorphic and myxoid/round cell LS. The larger subcluster was subdivided into three subsets, one with nearly exclusive overrepresentations of 12q13–q15, the second with additional frequent gains of 1q21–q24, and the third with further recurrent overrepresentations of 6q22–q24, 20q13, and 12q24 and frequent losses of 13q14–q21 and 11q22–q23. While the first subset comprised both well-differentiated and dedifferentiated LS, the second and third subsets entirely included dedifferentiated LS. The second main cluster was characterised by recurrent overrepresentations of 5p13–p15, 1q21–q24, 1p12–p21, and 17p11.2–p12 and essentially comprised pleomorphic and myxoid/round cell LS. A separation of this second main cluster into two subclusters was based on additional gains on 22q13 and losses on 1q42–q43. Genomic profiling reveals genetically distinct subsets of dedifferentiated LS, which are clearly different from pleomorphic, myxoid/round cell, and, for some subsets, from well-differentiated LS. These data indicate that dedifferentiated LS follow separate tumourigenic pathways and that genetic analysis is important to unravel these differences.
Similar content being viewed by others
References
Fletcher CDM, Unni K, Mertens K (2002) WHO classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon
Pedeutour F, Forus A, Coindre J-M et al (1999) Structure of supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24:30–41
Forus A, Weghuis DO, Smeets D et al (1995) Comparative genomic hybridization analysis of human sarcomas: I. occurrence of genomic imbalances and identification of a novel major amplicon at 1q21–q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14:8–14
Szymanska J, Virolainen M, Tarkkanen M et al (1997) Overrepresentation of 1q21–23 and 12q13–21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study. Cancer Genet Cytogenet 99:14–18
Dei Tos AP, Doglioni C, Piccinin S et al (2000) Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 190:531–536
Evans HL (1997) Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 3:507–523
Weiss SW, Rao VK (1992) Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of “dedifferentiation”. Am J Surg Pathol 16:1051–1058
McCormick D, Mentzel T, Beham A, Fletcher CDM (1994) Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol 18:1213–1223
Henricks WH, Chu Y-C, Goldblum JR, Weiss SW (1997) Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 21:271–281
Hasegawa T, Seki K, Hasegawa F et al (2000) Dedifferentiated liposarcoma of retroperitoneum and mesentery: varied growth patterns and histological grades: a clinicopathologic study of 32 cases. Hum Pathol 31:717–727
Huang H-Y, Brennan MF, Singer S, Antonescu CR (2005) Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation. Mod Pathol 18:976–984
Pilotti S, Della Torre G, Lavarino C et al (1997) Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 181:14–24
Sandberg AA (2004) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet 155:1–24
Kilpatrick SE, Doyon J, Choong PFM, Sim FH, Nascimento AG (1996) The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 77:1450–1458
Gebhard S, Coindre J-M, Michels J-J et al (2002) Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases. Am J Surg Pathol 26:601–616
Hornick JL, Bosenberg MW, Mentzel T et al (2004) Pleomorphic liposarcoma. Clinicopathologic analysis of 57 cases. Am J Surg Pathol 28:1257–1267
Downes KA, Goldblum JR, Montgomery EA, Fisher C (2001) Pleomorphic liposarcoma. A clinicopathologic analysis of 19 cases. Mod Pathol 14:179–184
Mertens F, Fletcher CDM, Dal Cin P et al (1998) Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP study group. Genes Chromosomes Cancer 22:16–25
Rieker RJ, Joos S, Bartsch C et al (2002) Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas. Int J Cancer 99:68–73
Fritz B, Schubert F, Wrobel G et al (2002) Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res 62:2993–2998
Schmidt H, Bartel F, Kappler M et al (2005) Gains of 13q are correlated with a poor prognosis in liposarcoma. Mod Pathol 18:638–644
Ibdaih A, Coindre J-M, Derré J et al (2005) Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 85:176–181
Kallioniemi OP, Kallioniemi A, Piper J et al (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231–243
Eisen MB, Spellman ST, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863–14868
Guillou L, Coindre JM, Bonichon F et al (1997) Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 15:350–362
Sakamoto A, Oda Y, Adachi T et al (2001) H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis. Am J Clin Pathol 115:235–242
Sakamoto A, Oda Y, Adachi T et al (2002) Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma. Arch Pathol Lab Med 126:1071–1078
Schneider-Stock R, Boltze C, Jaeger V et al (2002) Significance of loss of heterozygosity of the RB1 gene during tumour progressin in well-differentiated liposarcomas. J Pathol 197:654–660
Takahira T, Oda Y, Tamiya S et al (2005) Alterations of the RB1 gene in dedifferentiated liposarcoma. Mod Pathol 18:1461–1470
Singer S, Socci ND, Ambrosini G et al (2007) Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 67:6626–6636
Forus A, Larramendy ML, Meza-Zepeda LA et al (2001) Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22–q24 associated with metastases. Cancer Genet Cytogenet 125:100–111
Chibon F, Martiani O, Derrė J et al (2004) ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytoma with 12q14–q15 and 6q23 amplifications. Genes Chromosomes Cancer 40:32–37
Mechtersheimer G, Otaňo-Joos M, Ohl S et al (1999) Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer 25:362–369
El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M (1998) DNA copy number changes in development and progression of leiomyosarcomas of soft tissues. Am J Pathol 153:985–990
Otaňo-Joos M, Mechtersheimer G, Ohl S et al (2000) Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics. Cytogenet Cell Genet 90:86–92
Adamowicz M, Radlwimmer B, Rieker RJ et al (2006) Frequent amplifications and abundant expression of TRIO, NKD2, and IRX2 in soft tissue sarcomas. Genes Chromosomes Cancer 45:829–838
Wang R, Titley JC, Lu Y-J et al (2003) Loss of 13q14–q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod Pathol 16:778–785
Lau CC, Harris CP, Lu X-Y et al (2004) Frequent amplification and rearrangement of chromosomal bands 6p12–p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 79:11–21
Acknowledgements
The skilful technical and photographic assistance of Marion Moock and John Moyers is gratefully acknowledged. This study was supported by the Tumorzentrum Heidelberg/Mannheim, Germany (FSPI.1) and the Deutsche Krebshilfe.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Table 1
(DOC 189 KB)
Rights and permissions
About this article
Cite this article
Rieker, R.J., Weitz, J., Lehner, B. et al. Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways. Virchows Arch 456, 277–285 (2010). https://doi.org/10.1007/s00428-009-0869-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-009-0869-9